The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but without diabetes, highlighting its superior effectiveness and cardiometabolic ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

Fibre — predominantly found in beans, vegetables, whole grains, nuts and seeds — is the most notable nutrient that can significantly increase GLP-1. When fibre is fermented by the trillions of ...

Novo Nordisk (NYSE: NVO) stock jumped 3% through 10:55 a.m. Tuesday on some potentially positive news in the GLP-1 weight ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...

In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...